Prevounce Health launches new cellular-connected blood glucose meter for remote patient monitoring

US-based Prevounce Health, a leading provider of remote care management software, devices, and services, has announced the launch of its first remote blood glucose monitoring device: Pylo GL1-LTE.

The blood glucose meter is clinically validated and connects to multiple cellular networks to better ensure reliable data transmission throughout the United States. The GL1-LTE is available for use with the Prevounce remote care management platform and can integrate with other health software via the Pylo cloud API. Prevounce's line of Pylo cellular-connected devices also includes blood pressure monitors and weight scales.

The Pylo GL1-LTE is designed for use by patients enrolled in remote patient monitoring (RPM) programmes for diabetes. With roaming 4G connectivity, the device requires no configuration and securely transmits real-time readings to patient care teams.

Rigorously tested, FDA cleared, and FCC certified, the GL1-LTE delivers plasma glucose results with accuracy comparable to laboratory testing equipment. Patients benefit from an intuitive user interface, an easy-to-use test strip ejector mechanism, and a convenient carrying case that comes standard.

Healthcare organisations can personalise the GL1-LTE blood glucose meter to deliver a consistent brand experience. Pylo devices and their packaging are designed for easy customization, allowing for the addition of logos, taglines, patient inserts, and more. Prevounce also offers clients inventory and logistics support.